Barakat, A.; El-Senduny, F.F.; Islam, M.S.; Al-Majid, A.M.; Elshaier, Y.A.M.M.; Mazyed, E.A.; Badria, F.A.
Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma. Pharmaceutics 2025, 17, 93.
https://doi.org/10.3390/pharmaceutics17010093
AMA Style
Barakat A, El-Senduny FF, Islam MS, Al-Majid AM, Elshaier YAMM, Mazyed EA, Badria FA.
Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma. Pharmaceutics. 2025; 17(1):93.
https://doi.org/10.3390/pharmaceutics17010093
Chicago/Turabian Style
Barakat, Assem, Fardous F. El-Senduny, Mohammad Shahidul Islam, Abdullah Mohammed Al-Majid, Yaseen A. M. M. Elshaier, Eman A. Mazyed, and Farid A. Badria.
2025. "Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma" Pharmaceutics 17, no. 1: 93.
https://doi.org/10.3390/pharmaceutics17010093
APA Style
Barakat, A., El-Senduny, F. F., Islam, M. S., Al-Majid, A. M., Elshaier, Y. A. M. M., Mazyed, E. A., & Badria, F. A.
(2025). Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma. Pharmaceutics, 17(1), 93.
https://doi.org/10.3390/pharmaceutics17010093